During the past decade, Krankenhaus St. Josef conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 2 clinical trials were completed, i.e. on average, 33.3% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 2 clinical trials were completed. i.e. 66.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Krankenhaus St. Josef" #1 sponsor was "Janssen Pharmaceutica N.V., Belgium" with 2 trials, followed by "Janssen Research & Development, LLC" with 2 trials sponsored, "Bristol-Myers Squibb" with 1 trials sponsored, "Charite University, Berlin, Germany" with 1 trials sponsored and "Prof. Laszlo Czirjak" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Krankenhaus St. Josef" #1 collaborator was "Charite University, Berlin, Germany" with 1 trials as a collaborator, "European Union" with 1 trials as a collaborator, "Pro-Implant Foundation" with 1 trials as a collaborator, "Schoen Klinik Hamburg Eilbek" with 1 trials as a collaborator and "University College, London" with 1 trials as a collaborator. Other collaborators include 2 different institutions and companies that were collaborators in the rest 12 trials.

According to Clinical.Site data, the most researched conditions in "Krankenhaus St. Josef" are "Arthritis, Psoriatic" (4 trials), "Arthritis" (1 trials), "Prosthetic Joint Infection" (1 trials), "Sjogrens Disease" (1 trials) and "Systemic Sclerosis" (1 trials). Many other conditions were trialed in "Krankenhaus St. Josef" in a lesser frequency.

Most popular intervention types in "Krankenhaus St. Josef" are "Drug" (5 trials), "Biological" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (4 trials), "Guselkumab" (3 trials), "Abatacept" (1 trials), "Fosfomycin" (1 trials) and "Guselkumab 100 mg" (1 trials). Other intervention names were less common.

The vast majority of trials in "Krankenhaus St. Josef" are 7 trials for "All" genders.

Currently, there are NaN active trials in "Krankenhaus St. Josef". undefined are not yet recruiting, 2 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Krankenhaus St. Josef, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Krankenhaus St. Josef, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".